GlassScriptPhysician profile
Paul W Cump
NPI 1235193343
$4,075.05
in general payments reported to CMS, 2019-2025
18 companies · $88.63 in 2025
The $88.63 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,083 · 2020: $20.68 · 2021: $1,175 · 2022: $952 · 2023: $534 · 2024: $222 · 2025: $88.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $844.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,288.36 | 2019-2025 | Mavyret, Creon |
| Gilead Sciences, INC. | $876.42 | 2019-2024 | Epclusa |
| Biohaven Pharmaceuticals, INC. | $359.25 | 2021 | |
| Allergan, INC. | $219.75 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $195.85 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $166.30 | 2021 | |
| Amgen INC. | $134.92 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $126.34 | 2023 | |
| Eisai INC. | $124.72 | 2021 | |
| Pfizer INC. | $122.16 | 2019 | |
| Janssen Pharmaceuticals, INC | $89.35 | 2019-2022 | |
| Lilly USA, LLC | $87.24 | 2019 | |
| Intercept Pharmaceuticals, INC. | $78.99 | 2019 | |
| Sanofi-Aventis U.S. LLC | $74.51 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.80 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $39.80 | 2019-2020 | |
| Grifols USA, LLC | $21.84 | 2019 | |
| Sunovion Pharmaceuticals INC. | $19.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Cump listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.